מרונם 1 גרם

Pays: Israël

Langue: hébreu

Source: Ministry of Health

Ingrédients actifs:

MEROPENEM AS TRIHYDRATE

Disponible depuis:

PFIZER PFE PHARMACEUTICALS ISRAEL LTD

Code ATC:

J01DH02

forme pharmaceutique:

אבקה להכנת תמיסה לזריקה

Composition:

MEROPENEM AS TRIHYDRATE 1000 MG/VIAL

Mode d'administration:

תוך-ורידי

Type d'ordonnance:

מרשם נדרש

Fabriqué par:

ASTRA ZENECA UK LIMITED

Groupe thérapeutique:

MEROPENEM

Domaine thérapeutique:

MEROPENEM

indications thérapeutiques:

Meronem is indicated for treatment in adults and children of the following severe infections caused by single or multiple susceptible bacteria sensitive to meropenem: - Pneumonias and nosocomial pneumonias. - Pulmonary infections in patients with cystic fibrosis. - Urinary tract infections. - Intra-abdominal infections. - Gynecological infections such as endometritis and pelvic inflammatory disease. - Skin and skin structure infections. - Meningitis. - Septicemia. Meronem has proved efficacious alone or in combination with other antimicrobial agents in the treatment of polymicrobial infections. There is no experience in pediatric patients with neutropenia or primary or secondary immunodeficiency.

Date de l'autorisation:

2012-01-31